SLAS 2025 NexusXp
Join Virscidian, Biosero, and Waters at our NexusXp exhibit where we will be highlighting our work automating DeepCure's Drug Discovery Process

SLAS 2025 NexusXp
Discover the Power of Collaboration: Virscidian, Waters, and Biosero at SLAS2025 NexusXP exhibit.
Join us at the NexusXP exhibit at SLAS2025 to explore how Virscidian, Waters, and Biosero partnered to support DeepCure Laboratories' mission of revolutionizing drug discovery. By combining AI-driven design, advanced synthesis automation, and cutting-edge software tools, the team implemented a seamless workflow for DeepCure's molecular foundry. This innovative platform enables the automated synthesis, purification, and analysis of 5,000–10,000 lead-like compounds each month, accelerating the drug discovery process. Discover how these technologies come together to drive efficiency and innovation in modern laboratories.
Our Impact by Numbers
